Antisense compounds, compositions and methods are provided for modulating
the expression of Casein kinase 2-alpha prime. The compositions comprise
antisense compounds, particularly antisense oligonucleotides, targeted to
nucleic acids encoding Casein kinase 2-alpha prime. Methods of using these
compounds for modulation of Casein kinase 2-alpha prime expression and for
treatment of diseases associated with expression of Casein kinase 2-alpha
prime are provided.